Orthopedic Trauma Devices Market is expected to be worth US$ 21.2 billion by 2033 | FMI Analyst

The Orthopedic Trauma Devices Market is predicted to grow at a CAGR of 7.1% over the forecast period, according to FMI’s analysis. The industry’s estimated value is predicted to increase from US$ 10.7 Billion in 2023 to US$ 21.2 Billion by 2033. The market is poised to grow at a strong rate due to a …

Knee Hyaluronic Acid Injections Market are expected to reach US$ 3.0 billion by 2031 | Says FMI Analyst

 The global Knee Hyaluronic Acid Injection Market is expected to witness a stable growth rate of around 5.0% from 2021 to 2031. The global market revenue totaled US$ 1.9 Billion in 2021, according to the latest insights by Future Market Insights (FMI) survey. The overall sales of knee hyaluronic acid injections are expected to reach …

Rising Mental Health Issues Push Depression Treatment Market to reach US$ 16.8 Billion by 2032 | FMI Study

The global Depression Treatment Market is predicted to reach a valuation of US$ 16.8 Billion by 2032, with the market growing at a moderate CAGR of 5.2% from 2022 to 2032. Valued at US$ 9.7 Billion in 2021, the target market is expected to reach an estimated US$ 10.1 Billion in 2022. Different factors like …

Electric Vehicles Battery Heating System Market to Reach US$ 17289 Million by year 2033

The global electric vehicle battery heating system market is projected to register at a moderate-paced CAGR of 18.7% over the forecast period. The EV battery heating system market is currently valued at US$ 3113.6 Million in 2023. By 2033, demand for EV battery heating systems is expected to reach a high of US$ 17289 Million. …

Truck Mounted Knuckle Boom Cranes Market to expand at a CAGR of 5.1% by year 2032

The global Truck Mounted Knuckle Boom Cranes market share is anticipated to create opulent growth over the forecast period by generating a CAGR of 5.1% from 2022 to 2032. The global market grew from US$ 827.8 Million in 2022 to US$ 1,365.0 Million by 2032. Over 3/4th of the market for truck-mounted knuckle boom cranes …

3D Cell Culture Market to Regulate Revenue of US$ 2.67 Billion by 2031 Due to Increasing Focus on Developing Alternatives to Animal Testing

The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by …

IgA Nephropathy Market is expected to reach a valuation of US$ 85 Billion by 2033 | FMI

During the forecast period 2023-2033, the IgA Nephropathy Market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney …

Trimethoprim is expected to capture 40% of the Chronic Granulomatous Disease Market | FMI study

During the forecast period 2023-2033, the Chronic Granulomatous Disease (CGD) Management Market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Granulomatous disease (CGD) management is expected to rise up to a market valuation of US$ 2.11 Billion. It is …

Intestinal Fistula Treatment Market is expected to reach US$ 46.82 Billion | FMI

The global Intestinal Fistula Treatment Market is expected to be valued at US$ 26.64 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for intestinal fistula treatment is projected to grow at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 46.82 Billion by 2033. Factors such as …

Prinzmetal Angina Therapeutics Market is expected to reach a valuation of US$ 17.2 Billion by 2033 | FMI Report

The global Prinzmetal Angina Therapeutics Market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of …